Skip to content
PatentBrief
Get alertsTop ↑

How Tiny Fat Particles Deliver Medicines Deep Into Skin

This patent describes a method for delivering medicines into the skin using special nanoparticles made of fats, which are modified to easily pass through the skin's protective layers.

Granted 2014ActiveExpires 2029Owned by Florida Agricultural and Mechanical UniversityInvented by Mandip Singh Sachdeva, Ram Patlolla

Original patent title: “Nanoparticle formulations for skin delivery”

Plain-English explanation by SahiLast reviewed · November 4, 2026

This patent describes a method for delivering medicines into the skin using special nanoparticles made of fats, which are modified to easily pass through the skin's protective layers. Granted to Florida Agricultural and Mechanical University in 2014 with 11 claims and 34 forward citations, and it is expected to expire in 2029.

Coverage

What does this patent actually cover?

This patent claimsclaimsThe numbered statements at the end of a patent that legally define what the inventor owns.Read more → a special formulation for applying medicines to the skin. It uses tiny particles called nanostructured lipid carriers (NLCs) that encapsulate an active substance, like an anti-inflammatory agent (ClaimclaimA numbered sentence at the end of a patent that legally defines what the inventor owns. The most important section.Read more → 3). The surface of these NLCs is modified with a 'cell penetrating peptide' (Claim 1), which helps them get past the skin's outer barrier. These NLCs are made from a blend of solid and liquid fats that stay solid at body temperature, ensuring controlled release of the medicine. The formulation is designed to deliver the active substance specifically to the epidermis, reaching a depth of about 80 to 120 microns (Claim 1). For example, this could be used to treat conditions like psoriasis or eczema (Claim 5).

The gap

What does this patent NOT cover?

  • Does not cover skin delivery systems that do not use nanostructured lipid carrier nanoparticles.
  • Does not cover nanoparticles that are not surface-modified with a cell penetrating peptide.
  • Does not cover formulations where the blend of solid and liquid lipids is not solid at body temperature.
  • Does not cover delivery of active substances to skin depths outside the range of 80 to 120 microns.
  • Does not cover delivery methods that do not involve topical application to the skin.

These exclusions are unique to PatentBrief — derived from the actual claim language, not patent-office boilerplate.

Key facts

Patent numberUS 8715736
StatusActive
FieldBiotech & Medicine
AssigneeFlorida Agricultural and Mechanical University
InventorsMandip Singh Sachdeva, Ram Patlolla
Filed2009
Granted2014
Expires2029
Claims11
Times cited34
LitigationNone on record
Value · $90K–$288KModest

What made this novel

The truly clever part is combining nanostructured lipid carriers, which offer controlled release and stability, with cell-penetrating peptides on their surface. This dual approach allows the tiny particles to both carry the medicine effectively and actively 'pull' themselves through the tough skin barrier to a specific target depth, which was a significant challenge for topical drug delivery.

The Patent Drawing

Representative patent drawing for Nanoparticle formulations for skin delivery (US 8715736)
Representative figure · US 8715736All figures on Google Patents →
Nanoparticle formulations for …(Primary claim)pharmaceuticalbiotechmaterialsconsumer electronics

Schematic visualization of the patent's claim structure. Hand-drawn diagrams in progress for each landmark patent.

Where you've seen this

Real-world examples

01

Topical anti-inflammatory creams using advanced delivery systems

02

Dermatological treatments for psoriasis or eczema

03

Targeted skin cancer therapies applied directly to the skin

04

Formulations for treating localized bacterial or fungal skin infections

05

Cosmetic products designed for enhanced ingredient penetration

Why it matters

The bigger picture

The skin's outermost layer, the stratum corneum, is a very effective barrier, making it difficult for many medicines to penetrate deeply enough to treat underlying conditions. This patent offers a way to overcome that barrier, allowing for more targeted and effective treatment of skin diseases. By delivering active substances precisely to the epidermis, it can reduce side effects and improve the efficacy of topical drugs for conditions like inflammation, infections, and even skin cancer.

Filed

April 30, 2009

Granted

May 6, 2014

Market context

Who's building on this

Companies in this space

Many pharmaceutical companies and biotech startups are actively researching and developing nanoparticle-based drug delivery systems for dermatology. Companies like Galderma, L'Oreal (in cosmetics), and various specialty pharma firms are exploring advanced topical formulations. Florida Agricultural and Mechanical University, the assigneeassigneeThe entity that owns the patent — usually the inventor's employer or a company.Read more →, continues to be involved in research in this area, often collaborating with industry partners.

Market impact

This type of technology has significantly influenced the development of new topical drug formulations, moving beyond simple creams to more sophisticated delivery mechanisms. It has enabled the creation of products with improved efficacy and reduced systemic side effects for various skin conditions. The focus on targeted delivery has opened new avenues for treating chronic skin diseases and localized infections, impacting the dermatology and cosmetic pharmaceutical markets.

Claim 1 — Plain English

What this patent covers

This patent claims a special formulation for applying medicines to the skin. It uses tiny particles called nanostructured lipid carriers (NLCs) that encapsulate an active substance, like an anti-inflammatory agent (Claim 3). The surface of these NLCs is modified with a 'cell penetrating peptide' (Claim 1), which helps them get past the skin's outer barrier. These NLCs are made from a blend of solid and liquid fats that stay solid at body temperature, ensuring controlled release of the medicine. The formulation is designed to deliver the active substance specifically to the epidermis, reaching a depth of about 80 to 120 microns (Claim 1). For example, this could be used to treat conditions like psoriasis or eczema (Claim 5).

The clever bit

The truly clever part is combining nanostructured lipid carriers, which offer controlled release and stability, with cell-penetrating peptides on their surface. This dual approach allows the tiny particles to both carry the medicine effectively and actively 'pull' themselves through the tough skin barrier to a specific target depth, which was a significant challenge for topical drug delivery.

What it does not cover

  • Does not cover skin delivery systems that do not use nanostructured lipid carrier nanoparticles.
  • Does not cover nanoparticles that are not surface-modified with a cell penetrating peptide.
  • Does not cover formulations where the blend of solid and liquid lipids is not solid at body temperature.
  • Does not cover delivery of active substances to skin depths outside the range of 80 to 120 microns.
  • Does not cover delivery methods that do not involve topical application to the skin.

Patent timeline

Filing

Application submitted to the patent office

Publication

Application published, typically 18 months after filing

Grant

Patent officially issued

Expiration

Patent enters public domain

PatentBrief Score

Impact Score

Moderate

Citation count

31/40

Moderately cited

Claim breadth

7/20

Moderate scope

Recency

5/20

Granted 10–20 years ago

Assignee scale

0/20

Independent or smaller assigneeassigneeThe entity that owns the patent — usually the inventor's employer or a company.Read more →

PatentBrief Impact Score — based on citation count, claim breadth, recency, and assignee scale. Not a legal assessment.

Heuristic Value Estimate

What this patent might be worth

Modest

$90K – $288K

Midpoint $180K · 2.4 yr remaining · industry ×3.0

Adjust inputs →

Heuristic only — blends forward/backward citation counts, claim scope, time remaining, litigation history, and CPC-derived industry baseline. Real valuations need a professional appraisal.

Claim text not yet imported for this patent

The original legal language

Original claims

11 claims as filed with the patent office.

Concepts involved

ClaimPrior artNon-obviousnessNoveltySpecificationAssigneePatent term

Citations

Patent lineage

Cites earlier patents

4

earlier patents this invention cites as foundations

View prior art →

Cited by later patents

34

later patents that build on this invention

View patents →

Cite this patent

Sachdeva, M. S., & Patlolla, R. (2014). How Tiny Fat Particles Deliver Medicines Deep Into Skin (U.S. Patent No. 8,715,736). U.S. Patent and Trademark Office. https://patentbrief.org/patent/us/8715736/nanoparticle-formulations-for-skin-delivery

Auto-generated from the patent record. Double-check author order and the issue date against the official USPTO document before submitting.

Embed

Add this patent to your site

Drop this plain-English patent card into any blog post or article — free, no signup. It always links back to the full breakdown here.

<div data-patentlens-widget data-patent-number="US8715736"></div>
<script src="https://patentbrief.org/embed.js" async></script>

Stay in the loop

Get a weekly digest of new patents.

One email per week. No spam. Unsubscribe anytime.

Keep exploring

Related patents you should know

US 4683195 · 1987

How to Make Billions of Copies of a DNA Segment

This patent describes the Polymerase Chain Reaction (PCR), a method to rapidly create many copies of a specific piece of DNA or RNA, enabling its detection and analysis.

Cetus Corp

US 8697359 · 2014

How to Edit Genes in Human Cells Using an Engineered CRISPR System

This patent describes an engineered CRISPR-Cas9 system for precisely cutting DNA in eukaryotic cells to change how genes work, opening the door for gene editing in complex organisms.

Massachusetts Institute of Technology

US 7657849 · 2010

How the iPhone's Slide-to-Unlock Gesture Works

Apple's 2010 patent describes unlocking a device by dragging a specific graphical image across the touchscreen along a predefined path, a gesture that became iconic with the original iPhone.

Apple Inc

US 4733665 · 1988

How Doctors Implant a Permanent Stent Using a Balloon

This patent describes the method for placing a permanent, expandable wire mesh tube inside a blood vessel or other body tube using a balloon-tipped catheter to widen it and keep it open.

Expandable Grafts Partnership

US 4965188 · 1990

How to Make Many Copies of a DNA Piece with Heat

This patent describes the Polymerase Chain Reaction (PCR) method, a technique to make millions of copies of a specific DNA segment using a heat-resistant enzyme and repeated temperature changes.

Cetus Corp

US 4235871 · 1980

How to Encapsulate Active Materials in Lipid Bubbles Efficiently

This patent describes a method for trapping biologically active substances inside tiny, multi-layered fat bubbles called liposomes, using a specific water-in-oil emulsion and gel-forming process to improve how much material gets captured.

Individual

Semantically similar

You might also find these interesting

SEARCH ALL

More to explore

More in Biotech & Medicine

Browse all Biotech & Medicine

New to patents?

What is a patent?How to read a patentAnatomy of a claimHow strong is this patent?What the citations meanWhat it doesn't coverBiotech PatentsPatent glossary
Explore the landscape:pharmaceutical patents →biotech patents →materials patents →

Common Questions

Frequently Asked Questions

What does How Tiny Fat Particles Deliver Medicines Deep Into Skin cover?

This patent describes a method for delivering medicines into the skin using special nanoparticles made of fats, which are modified to easily pass through the skin's protective layers.

Who owns patent US 8715736?

Florida Agricultural and Mechanical University owns this patent, granted in 2014.

When does this patent expire?

This patent is expected to expire on April 30, 2029, when the invention enters the public domain.

What is patent US 8715736 cited by?

This patent has been cited by 34 later patents that build on its ideas.

What problem does this patent solve?

The skin's outermost layer, the stratum corneum, is a very effective barrier, making it difficult for many medicines to penetrate deeply enough to treat underlying conditions. This patent offers a way to overcome that barrier, allowing for more targeted and effective treatment of skin diseases. By delivering active substances precisely to the epidermis, it can reduce side effects and improve the efficacy of topical drugs for conditions like inflammation, infections, and even skin cancer.

What does this patent NOT cover?

Does not cover skin delivery systems that do not use nanostructured lipid carrier nanoparticles.

Patent monitoring

Get notified when Florida Agricultural and Mechanical University files a new patent

Get notified when this company files a new patent. Weekly digest · Confirm via email · Unsubscribe anytime.

Last reviewed: November 4, 2026 · PatentBrief is not a law firm and this is not legal advice.